Avadel Pharmaceuticals (AVDL) Accumulated Depreciation & Amortization (2016 - 2020)
Historic Accumulated Depreciation & Amortization for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q4 2020 value amounting to $1.1 million.
- Avadel Pharmaceuticals' Accumulated Depreciation & Amortization rose 5182.07% to $1.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.1 million, marking a year-over-year increase of 5182.07%. This contributed to the annual value of $1.1 million for FY2020, which is 5182.07% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Accumulated Depreciation & Amortization of $1.1 million as of Q4 2020, which was up 5182.07% from $714000.0 recorded in Q4 2019.
- In the past 5 years, Avadel Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $7.1 million in Q4 2017 and a low of $714000.0 during Q4 2019
- Over the past 5 years, Avadel Pharmaceuticals' median Accumulated Depreciation & Amortization value was $5.7 million (recorded in 2016), while the average stood at $4.3 million.
- In the last 5 years, Avadel Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 8973.11% in 2019 and then surged by 5182.07% in 2020.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Accumulated Depreciation & Amortization stood at $5.7 million in 2016, then grew by 25.18% to $7.1 million in 2017, then decreased by 2.54% to $7.0 million in 2018, then crashed by 89.73% to $714000.0 in 2019, then surged by 51.82% to $1.1 million in 2020.
- Its Accumulated Depreciation & Amortization was $1.1 million in Q4 2020, compared to $714000.0 in Q4 2019 and $7.0 million in Q4 2018.